KSC · 004310.KS
Hyundai Pharmaceutical Co., Ltd.
₩6,570-₩110 (-1.65%)
Hyundai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 58.83% below the high.
Loading market information…
KOE · 382150.KQ · KRW
Stock price
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
Oncocross Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 80.16% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Oncocross Co., Ltd. undertakes collaborative research initiatives to discover new drugs, partnering with a variety of pharmaceutical companies both within South Korea and abroad. The company offers a fresh paradigm for drug development by providing analytical insights derived from its advanced artificial intelligence drug discovery platform. Founded by Yi-Rang Kim on June 22, 2015, Oncocross operates from its headquarters located in Seoul, South Korea.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:28 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩6,570-₩110 (-1.65%)
Hyundai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 58.83% below the high.
₩2,790-₩85 (-2.96%)
iNtRON Biotechnology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 60.2% below the high.
₩12,330-₩20 (-0.16%)
CKD Bio Corp.’s quoted price sits in the lower half of its reported 52-week range, 50.48% below the high.
₩5,660-₩70 (-1.22%)
Ildong Holdings Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 67.04% below the high.
₩841-₩36 (-4.1%)
CG Invites Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 49.55% below the high.
₩4,060-₩25 (-0.61%)
Sugentech Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.79% below the high.
₩1,882+₩21 (+1.13%)
Cellid, Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 60.46% below the high.
₩4,675-₩185 (-3.81%)
Encell Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 77.68% below the high.
